Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam for Renal Colic
NCT05722782Phase 2Recruiting
- Sponsor
- Université de Monastir
- Start
- Jul 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of piroxicam in Renal colic (3 arms), sponsored by Université de Monastir. Primary endpoint: Efficacity of oral NSAI at 7 days. Started Jul 2023; status: recruiting.
02
Drugs
piroxicam
03
Conditions
Renal colic
Beyond the preview
Go deeper on NCT05722782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05722782.